Bicycle Therapeutics (BCYC) Return on Sales (2018 - 2026)

Bicycle Therapeutics has reported Return on Sales for 9 years, with the latest figure at 0.69% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales fell 62.0% year-over-year to 0.69%; the trailing twelve-month figure through Mar 2026 stood at 0.04% (down 3.0% YoY), and the FY2025 full-year result was 0.03%, down 3.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.69%, down from 0.01% in the prior quarter.
• The five-year high for Return on Sales was 0.34% in Q4 2024, with the low at 0.69% in Q1 2026.
• Historically, Return on Sales has averaged 0.09% across 5 years, with a median of 0.06% in 2025.
• Annual changes were most pronounced in 2024 — Return on Sales jumped 44 bps — and 2026, when it tumbled 62 bps.
• Bicycle Therapeutics' Return on Sales stood at 0.04% in 2022, then sank by 160 bps to 0.1% in 2023, then surged by 447 bps to 0.34% in 2024, then tumbled by 102 bps to 0.01% in 2025, then sank by 12148 bps to 0.69% in 2026.
• The last three Return on Sales figures came in at 0.69% (Q1 2026), 0.01% (Q4 2025), and 0.05% (Q3 2025), per Business Quant data.